Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRG2010 in Parkinson's Disease With Motor Fluctuations
NCT06596876Phase 3Completed
- Sponsor
- Hengrui
- Start
- Nov 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HRG2010(II) in Parkinson's disease (PD), sponsored by Hengrui. Started Nov 2024; status: completed.
02
Drugs
HRG2010(II)
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06596876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06596876.